Having escaped the axeman in 2001, Tanishq became the undisputed jewel in Titan's crown. But despite his confidence in the jewellery brand, Managing Director Bhaskar Bhat is also counting on Titan Eye Plus and Fastrack to meet the company's 20 percent growth target consistently. And, as recent numbers show, his faith is not misplaced
Through organisational transformation and by reshaping business strategy, Harsh Mariwala is giving his company its best shot at growth in a competitive, ever-changing landscape
After hitting $100 million in revenue in its first six years, Mindtree lost its way. The IT services firm, though, can still catch up with the big league, but it will first have to stop thinking 'mid-tier'
With a spot in the top three as its target, Mankind Pharma, currently eighth-ranked, is focusing on chronic therapies and exports for growth impetus
The Kolkata-based giant has successfully become more than its cigarette brands. Now, Rajiv Kumar's company, best known for its tobacco-based products, is following suit and aggressively diversifying into other segments in a bid to reposition itself
There are apprehensions on whether Dilip Shanghvi's company can help India's largest but troubled pharma major turn around. However, analysts, while sceptical, also point out that Sun Pharma has a better shot than most
How Milestone Capital's Rubi Arya overcame personal tragedy to provide stability and growth to the PE fund. Here's her story in her own words